Biosceptre   Report issue

For profit Phase 1
Founded: Sydney NSW Australia (2000)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2013
NCT02587819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Scientific Director - Biosceptre